Anthem experts testify Cigna merger won’t hurt competition
Anthem Inc. fired back against U.S. claims that the health insurer’s planned $48 billion takeover of rival Cigna Corp. will undermine competition.
Anthem Inc. fired back against U.S. claims that the health insurer’s planned $48 billion takeover of rival Cigna Corp. will undermine competition.
Anthem Inc.’s proposed $48 billion merger with Cigna Corp. could give the insurer the power to raise prices for employers across the country, according to a witness in the U.S. government’s lawsuit to block the deal.
Pharmaceutical company stocks were among the winners in early trading Wednesday as Republicans’ sweeping election victory eased concerns that Democrats would enact controls on drug prices. Eli Lilly and Co. shares jumped 4 percent.
If Indianapolis-based Anthem retreats from the Affordable Care Act, it would mean that almost all of the major American for-profit health insurers have substantially pulled back from the law.
The health insurance giant saw its largest expense, medical claims paid, climb more than 9 percent in the quarter, to $16.92 billion.
Letters and emails between the two companies might become evidence in the Justice Department’s lawsuit seeking to halt the $48 billion deal.
Anthem Inc. and Cigna Corp. are refusing to provide letters between the two insurers that the U.S. government contends will show that they get along so poorly that they wouldn’t be able to effectively merge.
President Barack Obama met with top executives from more than a dozen health insurers on Monday to re-affirm his support for the Affordable Care Act after several companies retreated from the law’s government-run insurance markets.
Health insurer Cigna Corp., which has an agreement to be acquired by Anthem Inc., won’t be able to sign customers for its private Medicare plans during the fall enrollment season because of an investigation by U.S. regulators.
Hoosiers looking for health insurance on the Obamacare marketplace for next year will see fewer choices and double-digit premium increases on most plans, the Indiana Department of Insurance said Thursday.
No one is sure whether Anthem and the Justice Department can hash out a settlement before the federal case to block the insurer's $54 billion acquisition of Cigna Corp. goes to trial in November.
The decision by Aetna is the latest blow to President Obama’s signature domestic policy law. While it has brought coverage to millions, the new markets have proven volatile for some of the largest for-profit insurers.
Anthem Inc. will go to trial against the U.S. in late November to defend its $48 billion takeover of rival insurer Cigna Corp., a start date later than Anthem said it needed to potentially close the deal by an April deadline.
Investors appeared emboldened by remarks from a Justice Department lawyer Friday that the government was willing to hear settlement offers in its antitrust case involving the merger of the two insurers.
The Anthem-Cigna case was assigned to Judge Amy Berman Jackson, who was appointed to the bench by President Barack Obama. She set a scheduling conference for Aug. 12
Cigna Corp. CEO David Cordani faces a tough task: persuading investors and lawyers that the health insurer is committed to a $48 billion takeover by Indianapolis-based Anthem Inc., while also talking up its prospects as an independent company.
Anthem’s lawyer, Christopher Curran, told U.S. District Judge John Bates in Washington, D.C., on Thursday that Cigna’s top management is "no longer interested in being pursued."
Health care insurance giant Aetna Inc., facing more than $300 million in losses from Affordable Care Act health plans this year, may exit Obamacare markets.
Indianapolis-based Anthem Inc. has asked for an average 26.8 percent rate increase for individual plans offered on and off the state's health insurance exchange.
The Indianapolis-based health insurer said its participation in the government’s health insurance exchanges—a sore subject for the Obama administration that is trying to stop the acquisition—may be at stake.